Air Liquide Completes the Divestiture of schülke
03 August 2020 - 4:45PM
Business Wire
Regulatory News:
In accordance with its announcement on April 7, 2020, Air
Liquide (Paris:AI) has closed the sale of its subsidiary schülke to
EQT, a global investment organization. The total value of the
transaction, which is subject to an earn-out provision, is between
925 million euros and 1.0 billion euros.
This transaction illustrates Air Liquide’s strategy to review
its business portfolio regularly and to focus on its core gases and
healthcare businesses, thereby enhancing Air Liquide’s
performance.
Air Liquide intends to continue to develop its healthcare
activities, while providing Schülke & Mayr GmbH with the best
opportunity for its long-term development.
Schülke & Mayr GmbH
Schülke & Mayr GmbH, headquartered in Germany, is a leader in
infection prevention and hygiene for more than 130 years. schülke
develops, produces and distributes antiseptics for wound care,
disinfectants, medical and cosmetic skin care products and
preservatives. The company offers its customers innovative
products, technologies and services in its core business fields:
Healthcare, Industrial Hygiene and Personal Care. Schülke’s mission
is to protect lives worldwide and therewith actively contributes to
patient safety. Today, the company employs over 1,250 employees
worldwide and sells its products in over 100 countries. Represented
by 22 subsidiaries, schülke operates three production sites in
Germany (schülke), France (Bioxal) and Brazil (Vic Pharma).
www.schuelke.com
About EQT EQT is a
differentiated global investment organization with more than EUR 62
billion in raised capital and around EUR 40 billion in assets under
management across 19 active funds. EQT funds have portfolio
companies in Europe, Asia and the US with total sales of more than
EUR 27 billion and approximately 159,000 employees. EQT works with
portfolio companies to achieve sustainable growth, operational
excellence and market leadership.
A world leader in gases, technologies and services for Industry
and Health, Air Liquide is present in 80 countries with
approximately 67,000 employees and serves more than 3.7 million
customers and patients. Oxygen, nitrogen and hydrogen are essential
small molecules for life, matter and energy. They embody Air
Liquide’s scientific territory and have been at the core of the
company’s activities since its creation in 1902.
Air Liquide’s ambition is to be a leader in its industry,
deliver long term performance and contribute to sustainability. The
company’s customer-centric transformation strategy aims at
profitable, regular and responsible growth over the long term. It
relies on operational excellence, selective investments, open
innovation and a network organization implemented by the Group
worldwide. Through the commitment and inventiveness of its people,
Air Liquide leverages energy and environment transition, changes in
healthcare and digitization, and delivers greater value to all its
stakeholders.
Air Liquide’s revenue amounted to 22 billion euros in 2019 and
its solutions that protect life and the environment represented
more than 40% of sales. Air Liquide is listed on the Euronext Paris
stock exchange (compartment A) and belongs to the CAC 40, EURO
STOXX 50 and FTSE4Good indexes.
www.airliquide.com Follow us on Twitter
@airliquidegroup
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200802005013/en/
Corporate Communications media@airliquide.com
Investor Relations IRTeam@airliquide.com
Air Liquide (EU:AI)
Historical Stock Chart
From Apr 2024 to May 2024
Air Liquide (EU:AI)
Historical Stock Chart
From May 2023 to May 2024